• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Citrus Support for the Blood Glucose-Immune System Connection

    A Glance At The Eye Health Market

    The Value of Vitamin D Testing

    A Growing Need for Mineral Supplementation

    More Than Just A Trend: Supplements Embedded in Consumer Health Regimens
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    Martin Bauer Group Acquires Majority Stake in Beverage Company Power Brands

    Gencor Announces Positive Results in VeriSperse Bioavailability Study

    PanTheryx Inc. Acquires TruBiotics Brand from Bayer HealthCare LLC

    Nutrition21 Launches Cosmeceutical Ingredient Lustriva

    Indena Becomes First Company in Italy Authorized to Produce CBD
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    Martin Bauer Group Acquires Majority Stake in Beverage Company Power Brands

    Gencor Announces Positive Results in VeriSperse Bioavailability Study

    PanTheryx Inc. Acquires TruBiotics Brand from Bayer HealthCare LLC

    Nutrition21 Launches Cosmeceutical Ingredient Lustriva

    Indena Becomes First Company in Italy Authorized to Produce CBD
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    Martin Bauer Group Acquires Majority Stake in Beverage Company Power Brands

    Gencor Announces Positive Results in VeriSperse Bioavailability Study

    PanTheryx Inc. Acquires TruBiotics Brand from Bayer HealthCare LLC

    Nutrition21 Launches Cosmeceutical Ingredient Lustriva

    Indena Becomes First Company in Italy Authorized to Produce CBD
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    Gencor Announces Positive Results in VeriSperse Bioavailability Study

    PanTheryx Inc. Acquires TruBiotics Brand from Bayer HealthCare LLC

    Nutrition21 Launches Cosmeceutical Ingredient Lustriva

    Preliminary Study Links Markers of Impaired Bone Health to Vegan Diet

    Refined Grains Linked to Heart Attack Risk, Early Death
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    Verdure Sciences

    KLK OLEO - Davos Life Science

    AIDP

    Indena USA, Inc.

    Sabinsa Corporation
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    Sabinsa Corporation

    Indena USA, Inc.

    Aiya America (Matcha by Aiya)

    Bioenergy Life Science, Inc. (BLS)

    Nutrition21, LLC
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    FDA Approves First Drug with Active Ingredient Derived from Marijuana

    Agency prepared to take action against ‘illegal marketing of CBD-containing products with serious, unproven medical claims.'

    FDA Approves First Drug with Active Ingredient Derived from Marijuana
    Related CONTENT
    • Sunflower Hemp Co
    • Confusion Over Cannabis & The Fate of CBD
    • FDA Expands List of Ingredients Approved as Dietary Fiber
    • Taking Aim at the Global Heart Health Crisis
    • Petition Seeks Health Claim for Vitamin D, Lower Risk of Preterm Birth
    06.25.18
    The U.S. Food and Drug Administration has approved Epidiolex (cannabidiol) [CBD] oral solution to GW Research Ltd. for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, in patients two years of age and older. This is the first FDA-approved drug that contains a purified drug substance derived from marijuana. It is also the first FDA approval of a drug for the treatment of patients with Dravet syndrome.
     
    CBD is a chemical component of the Cannabis sativa plant, more commonly known as marijuana. However, CBD does not cause intoxication or euphoria (the “high”) that comes from tetrahydrocannabinol (THC). It is THC (and not CBD) that is the primary psychoactive component of marijuana.
     
    “This approval serves as a reminder that advancing sound development programs that properly evaluate active ingredients contained in marijuana can lead to important medical therapies. And, the FDA is committed to this kind of careful scientific research and drug development,” said FDA Commissioner Scott Gottlieb, MD. “Controlled clinical trials testing the safety and efficacy of a drug, along with careful review through the FDA’s drug approval process, is the most appropriate way to bring marijuana-derived treatments to patients. Because of the adequate and well-controlled clinical studies that supported this approval, prescribers can have confidence in the drug’s uniform strength and consistent delivery that support appropriate dosing needed for treating patients with these complex and serious epilepsy syndromes. We’ll continue to support rigorous scientific research on the potential medical uses of marijuana-derived products and work with product developers who are interested in bringing patients safe and effective, high quality products. But, at the same time, we are prepared to take action when we see the illegal marketing of CBD-containing products with serious, unproven medical claims. Marketing unapproved products, with uncertain dosages and formulations can keep patients from accessing appropriate, recognized therapies to treat serious and even fatal diseases.”
     
    Dravet syndrome is a rare genetic condition that appears during the first year of life with frequent fever-related seizures (febrile seizures). Later, other types of seizures typically arise, including myoclonic seizures (involuntary muscle spasms). Additionally, status epilepticus, a potentially life-threatening state of continuous seizure activity requiring emergency medical care, may occur. Children with Dravet syndrome typically experience poor development of language and motor skills, hyperactivity and difficulty relating to others.
     
    Lennox-Gastaut syndrome begins in childhood. It is characterized by multiple types of seizures. People with Lennox-Gastaut syndrome begin having frequent seizures in early childhood, usually between ages 3 and 5. More than three-quarters of affected individuals have tonic seizures, which cause the muscles to contract uncontrollably. Almost all children with Lennox-Gastaut syndrome develop learning problems and intellectual disability. Many also have delayed development of motor skills such as sitting and crawling. Most people with Lennox-Gastaut syndrome require help with usual activities of daily living.
     
    “The difficult-to-control seizures that patients with Dravet syndrome and Lennox-Gastaut syndrome experience have a profound impact on these patients’ quality of life,” said Billy Dunn, MD, director of the Division of Neurology Products in the FDA’s Center for Drug Evaluation and Research. “In addition to another important treatment option for Lennox-Gastaut patients, this first-ever approval of a drug specifically for Dravet patients will provide a significant and needed improvement in the therapeutic approach to caring for people with this condition.”
     
    Epidiolex’s effectiveness was studied in three randomized, double-blind, placebo-controlled clinical trials involving 516 patients with either Lennox-Gastaut syndrome or Dravet syndrome. Epidiolex, taken along with other medications, was shown to be effective in reducing the frequency of seizures when compared with placebo.
     
    The most common side effects that occurred in Epidiolex-treated patients in the clinical trials were: sleepiness, sedation and lethargy; elevated liver enzymes; decreased appetite; diarrhea; rash; fatigue, malaise and weakness; insomnia, sleep disorder and poor quality sleep; and infections.
     
    Epidiolex must be dispensed with a patient Medication Guide that describes important information about the drug’s uses and risks. As is true for all drugs that treat epilepsy, the most serious risks include thoughts about suicide, attempts to commit suicide, feelings of agitation, new or worsening depression, aggression and panic attacks. Epidiolex also caused liver injury, generally mild, but raising the possibility of rare, but more severe injury. More severe liver injury can cause nausea, vomiting, abdominal pain, fatigue, anorexia, jaundice and/or dark urine.
     
    Under the Controlled Substances Act (CSA), CBD is currently a Schedule I substance because it is a chemical component of the cannabis plant. In support of this application, the company conducted nonclinical and clinical studies to assess the abuse potential of CBD.
     
    The FDA prepares and transmits, through the U.S. Department of Health and Human Services, a medical and scientific analysis of substances subject to scheduling, like CBD, and provides recommendations to the Drug Enforcement Administration (DEA) regarding controls under the CSA. DEA is required to make a scheduling determination.
     
    The FDA granted Priority Review designation for this application. Fast-Track designation was granted for Dravet syndrome. Orphan Drug designation was granted for both the Dravet syndrome and Lennox-Gastaut syndrome indications.
    Related Searches
    • Children
    • fda
    • Enzymes
    • Research
    Related Knowledge Center
    • Regulations
    • Herbs & Botanicals
    Suggested For You
    Sunflower Hemp Co Sunflower Hemp Co
    Confusion Over Cannabis & The Fate of CBD Confusion Over Cannabis & The Fate of CBD
    FDA Expands List of Ingredients Approved as Dietary Fiber FDA Expands List of Ingredients Approved as Dietary Fiber
    Petition Seeks Health Claim for Vitamin D, Lower Risk of Preterm Birth Petition Seeks Health Claim for Vitamin D, Lower Risk of Preterm Birth
    Taking Aim at the Global Heart Health Crisis Taking Aim at the Global Heart Health Crisis
    FDA Warns Against Products Claiming to Replace Sunscreen FDA Warns Against Products Claiming to Replace Sunscreen
    FDA Extends Nutrition Facts Label Compliance Dates FDA Extends Nutrition Facts Label Compliance Dates
    FDA Cracks Down on Highly Concentrated Caffeine in Dietary Supplements FDA Cracks Down on Highly Concentrated Caffeine in Dietary Supplements
    New York Dietary Supplement Manufacturer Ordered to Stop Selling Products New York Dietary Supplement Manufacturer Ordered to Stop Selling Products
    Raphael Mechoulam Receives ABC Norman R. Farnsworth Excellence in Botanical Research Award Raphael Mechoulam Receives ABC Norman R. Farnsworth Excellence in Botanical Research Award
    FDA Releases Guidance on Dietary Fiber and Added Sugars FDA Releases Guidance on Dietary Fiber and Added Sugars
    Solid Dosage Outsourcing Trends Solid Dosage Outsourcing Trends

    Related Breaking News

    • Breaking News | Contract Manufacturing | Delivery & Dosage Technologies | Functional Foods & Beverages | Herbs & Botanicals | Industry & Market News | Mergers & Acquisitions | Packaging | World Markets
      Martin Bauer Group Acquires Majority Stake in Beverage Company Power Brands

      Martin Bauer Group Acquires Majority Stake in Beverage Company Power Brands

      Innovation in plant-based foods and beverages is seen by the company as critical to boosting long-term growth.
      Mike Montemarano, Associate Editor 03.01.21

    • Cognitive Function | Contract Manufacturing | Delivery & Dosage Technologies | Dietary Supplements | Energy | Healthy Aging | Herbs & Botanicals | Mood Health & Sleep | Quality & Safety | Research | Supplier News | Testing
      Gencor Announces Positive Results in VeriSperse Bioavailability Study

      Gencor Announces Positive Results in VeriSperse Bioavailability Study

      A double-blind, placebo-controlled trial showed similar bioavailability between a 75 mg dose of VeriSperse and a 150 mg dose of standard resveratrol.
      Mike Montemarano, Associate Editor 03.01.21

    • Breaking News | Contract Manufacturing | Dietary Supplements | Healthcare Trends | Herbs & Botanicals | Medical Nutrition | Natural/Organic | Supplier News | World Markets
      Indena Becomes First Company in Italy Authorized to Produce CBD

      Indena Becomes First Company in Italy Authorized to Produce CBD

      The company will produce pharmaceutical-grade CBD for the international market, using an Italian biomass.
      Mike Montemarano, Associate Editor 03.01.21


    • Breaking News | Contract Manufacturing | Functional Foods & Beverages | Healthcare Trends | Quality & Safety | Regulations | Regulatory News | Testing
      New FDA Traceability Rule Appears to Omit Dietary Supplement Manufacturers

      New FDA Traceability Rule Appears to Omit Dietary Supplement Manufacturers

      While the agency has not specifically confirmed it, dietary supplements were not mentioned in a list of manufacturers required to enhance traceability measures.
      Mike Montemarano, Associate Editor 02.25.21

    • Breaking News | Delivery & Dosage Technologies | Herbs & Botanicals | Supplier News
      JRF Technology Debuts Elderberry Oral Film Strip

      JRF Technology Debuts Elderberry Oral Film Strip

      Surveys have shown that four out of 10 North Americans report having difficulty swallowing pills.
      Sean Moloughney, Editor 02.23.21

    • Breaking News | Dietary Supplements | Healthcare Trends | Immune Function | Industry & Market News | Medical Nutrition | Regulations | Regulatory News | Vitamins | World Markets
      House Resolution Calls for CDC and FDA to Back Vitamin D for COVID-19

      House Resolution Calls for CDC and FDA to Back Vitamin D for COVID-19

      U.S. Representative Glenn Grothman (R-WI) believes the agencies should further communications and investigations on the risks of vitamin D deficiency.
      Mike Montemarano, Associate Editor 02.22.21


    • Contract Manufacturing | Dietary Supplements | People News | Quality & Safety | Regulations | Testing | World Markets
      Steven Tave to Leave FDA ODSP Director Position

      Steven Tave to Leave FDA ODSP Director Position

      With Dr. Cara Welch as acting ODSP director, Tave will go on to direct Strategic Planning and Operational Policy.
      Mike Montemarano, Associate Editor 02.22.21

    • Breaking News | Dietary Supplements | Digestive Health | Herbs & Botanicals | Inflammation | Mood Health & Sleep | Natural/Organic | Research | Research News | World Markets
      Curcuminoid Complex Study Evidences Benefits to Gut Health and Mood

      Curcuminoid Complex Study Evidences Benefits to Gut Health and Mood

      While no gut microbiome changes were recorded, Curcugen supplementation improved measures of GI discomfort and an improved mood.
      Mike Montemarano, Associate Editor 02.18.21

    • Breaking News | Dietary Supplements | Industry & Market News | Mergers & Acquisitions | Omega-3s | Regulations | Research | World Markets
      GOED Announces Partnership with Peruvian Omega-3s Group SNP

      GOED Announces Partnership with Peruvian Omega-3s Group SNP

      11 key Peruvian fishing companies are now members of GOED.
      Mike Montemarano, Associate Editor 02.18.21


    • Breaking News | Cardiovascular Health | Certifications, Approvals & Patents | Dietary Supplements | Herbs & Botanicals | Regulations | Weight Management/Weight Loss | World Markets
      PLT Health Solutions Granted Expanded License for Weight Management Ingredient from Health Canada

      PLT Health Solutions Granted Expanded License for Weight Management Ingredient from Health Canada

      New claims for Slendacor include claims related to healthy weight loss and support for healthy cholesterol and triglycerides.
      Mike Montemarano, Associate Editor 02.17.21

    • Breaking News | Certifications, Approvals & Patents | Cognitive Function | Herbs & Botanicals | Supplier Insights
      Proprietary Alpinia galangal, enXtra, Granted Patent for Cognitive Performance

      Proprietary Alpinia galangal, enXtra, Granted Patent for Cognitive Performance

      Formulation was also recently certified by Informed Ingredient, a quality assurance accreditation for manufacturing facilities.
      Sean Moloughney, Editor 02.16.21

    • Breaking News | Dietary Supplements | Infant & Children's Health | Medical Nutrition | Omega-3s | Regulations | Regulatory News | Research | Sexual & Reproductive Health | Women's Health | World Markets
      Omega-3s Recommended in Australian Pregnancy Guidelines Update

      Omega-3s Recommended in Australian Pregnancy Guidelines Update

      This recommendation was approved by the National health and Medical Research Council for the national 2020-2025 guidelines.
      Mike Montemarano, Associate Editor 02.11.21


    • Bone & Joint Health | Breaking News | Dietary Supplements | Healthcare Trends | Herbs & Botanicals | Inflammation | Medical Nutrition | Natural/Organic | Research | Supplier News | World Markets
      Preliminary Research Suggests Osteoarthritis Benefits for Herbal Formula JointAlive

      Preliminary Research Suggests Osteoarthritis Benefits for Herbal Formula JointAlive

      Chenland Nutritionals’ formula saw significant results in an animal study, with a human clinical trial slated for completion in 2022.
      Mike Montemarano, Associate Editor 02.11.21

    • Breaking News | Cardiovascular Health | Herbs & Botanicals | Research | Research News
      Cannabis Shown to Reduce Blood Pressure in Older Adults

      Cannabis Shown to Reduce Blood Pressure in Older Adults

      Researchers found a significant reduction in 24-hour systolic and diastolic blood pressure values.
      Sean Moloughney, Editor 02.09.21

    • Breaking News | Delivery & Dosage Technologies | Herbs & Botanicals | Research | Research News
      CBD Pharmacokinetics Study Compares Absorption Rate of Various Product Formats

      CBD Pharmacokinetics Study Compares Absorption Rate of Various Product Formats

      Published human study conducted by Colorado State University funded by Caliper Foods.
      Sean Moloughney, Editor 02.09.21

    Trending
    • Nestlé To Sell North American Water Brands
    • House Resolution Calls For CDC And FDA To Back Vitamin D For COVID-19
    • Innova: Top Trends In Dairy Focus On Holistic Benefits
    • Carlson Launches New Grade Of Astaxanthin Gummies With Astaferm
    • Curcuminoid Complex Study Evidences Benefits To Gut Health And Mood
    Breaking News
    • Martin Bauer Group Acquires Majority Stake in Beverage Company Power Brands
    • Gencor Announces Positive Results in VeriSperse Bioavailability Study
    • PanTheryx Inc. Acquires TruBiotics Brand from Bayer HealthCare LLC
    • Nutrition21 Launches Cosmeceutical Ingredient Lustriva
    • Indena Becomes First Company in Italy Authorized to Produce CBD
    View Breaking News >
    CURRENT ISSUE

    Jan/Feb 2021

    • Modern Snacking: Where Health & Indulgence Converge
    • More Than Just A Trend: Supplements Embedded in Consumer Health Regimens
    • A Growing Need for Mineral Supplementation
    • The Value of Vitamin D Testing
    • A Glance At The Eye Health Market
    • Citrus Support for the Blood Glucose-Immune System Connection
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Martin Bauer Group Acquires Majority Stake in Beverage Company Power Brands
    Gencor Announces Positive Results in VeriSperse Bioavailability Study
    PanTheryx Inc. Acquires TruBiotics Brand from Bayer HealthCare LLC
    Coatings World

    Latest Breaking News From Coatings World

    Mule-Hide Products Co. Promotes Steven Litaker to Territory Manager
    Terra Firma, Wanhua Announce New Distribution Partnership
    Gelest CEO Elected to National Academy of Engineering
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Axonics Buys Contura to Expand to Stress Urinary Incontinence
    Nurx Appoints Chief Medical Officer
    Median Technologies, UC San Diego to Partner on AI-Based Medical Imaging Technology
    Contract Pharma

    Latest Breaking News From Contract Pharma

    J&J’s Single-Dose COVID-19 Vax Issued EUA
    Icon to Acquire PRA Health Sciences
    Phlow Corp. and USP Form Alliance
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Universal Engraving Announces New President
    Raw Sugar Living Expands to Target with New Collection
    Supporting Female Beauty Brand Founders on International Women's Day
    Happi

    Latest Breaking News From Happi

    ACI and CBC Launch Webpage About ‘Quats’
    L’Occitane Launches Hand Cream Inspired by Women
    Kiehl’s Partners with Gyrl Wonder
    Ink World

    Latest Breaking News From Ink World

    Access Direct Mail Doubles Revenue with SCREEN's Truepress Jet520HD
    Etiflex Enters New Markets with Nilpeter FA-22 Installation
    Hydrocarbon Solvents Market to Surpass $8.1 Billion by 2030
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    TLMI analyzes pandemic's effect on label industry in new report
    UEI names Ross Hutchison president
    Schreiner MediPharm and AARDEX partner for clinical trials
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    U.S. Nonwovens Rebrands as Radienz Living
    What You’re Reading on Nonwovens-Industry.com
    Texas Medical Technology Partners with My Protect Kit
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Pandemic Pain: NuVasive's 2020 Sales Fall 10 Percent
    Fusion Robotics Receives FDA Clearance for Spinal Navigation and Robotics System
    Kaia Health Unveils Next-Gen Complete MSK Care Solutions
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Comercial Kywi Improves Customer Service, Front-Store Operations with Zebra Mobile Solution
    Global Printed Circuit Board Market Projected to Reach $69.32 Billion by 2027
    Global Smart Glass Market to Register 6.8% CAGR Between 2021-28: Grand View Research

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login